Stocks · Health care · Pharmaceutical Preparations

Theravance Biopharma, Inc.

TBPH Clue Score61
United States Fiscal year ends December CIK 0001583107 Results filed 10 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
6,657
$17.03
$113.40K
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,328
$17.03
$56.69K
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,329
$17.03
$56.71K
Eli Samaha
1 Jul 2026
10% owner
Sell indirect
37,799
$17.00
$642.63K
Eli Samaha
30 Jun 2026
10% owner
Sell indirect
25,027
$17.13
$428.79K
Eli Samaha
29 Jun 2026
10% owner
Sell indirect
273,871
$17.23
$4.72M
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
6,657
$16.39
$109.08K
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,328
$16.38
$54.53K
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,329
$16.39
$54.56K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
7,766
$13.92
$108.07K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
15,534
$14.00
$217.48K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
7,767
$13.92
$108.09K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
15,534
$18.75
$291.25K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
7,766
$18.75
$145.62K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
7,767
$18.75
$145.63K
Eran Broshy
26 Nov 2025
Director
Sold after exercise
15,501
$20.00
$310.02K
Eran Broshy
26 Nov 2025
Director
Sold after exercise
14,000
$20.00
$280.00K
Eran Broshy
11 Nov 2025
Director
Sold after exercise
14,000
$18.50
$259.00K
Eran Broshy
11 Nov 2025
Director
Sold after exercise
15,500
$17.00
$263.50K
Eran Broshy
11 Nov 2025
Director
Sold after exercise
29,500
$18.50
$545.75K
Rhonda Farnum
14 Jul 2025
SVP, Comm & Medical Affairs
Sold on a plan
4,000
$11.39
$45.55K
Rhonda Farnum
14 Jul 2025
SVP, Comm & Medical Affairs
Sold on a plan
5,318
$11.39
$60.55K
Rhonda Farnum
14 Jul 2025
SVP, Comm & Medical Affairs
Sold on a plan
682
$11.39
$7.77K
Rhonda Farnum
2 Jun 2025
SVP, Comm & Medical Affairs
Sold on a plan
24,000
$11.00
$264.00K
Rhonda Farnum
21 Apr 2025
SVP, Comm & Medical Affairs
Sold on a plan
4,000
$9.00
$36.00K
Rhonda Farnum
21 Jan 2025
SVP, Comm & Medical Affairs
Sold on a plan
4,000
$9.00
$36.00K
Rhonda Farnum
11 Nov 2024
SVP, Comm & Medical Affairs
Sell
4,000
$9.00
$36.00K
Eli Samaha
7 Aug 2024
10% owner
Buy indirect
999,800
$7.80
$7.80M
Rhonda Farnum
10 Jul 2024
SVP, Comm & Medical Affairs
Sold on a plan
4,000
$9.00
$36.00K
Eli Samaha
1 May 2024
10% owner
Buy indirect
499,324
$8.75
$4.37M
Eli Samaha
1 May 2024
10% owner
Buy indirect
999,800
$8.75
$8.75M
Rhonda Farnum
22 Feb 2024
SVP, Comm & Medical Affairs
Sold on a plan
1,254
$8.71
$10.92K
Rhonda Farnum
21 Nov 2023
SVP, Comm & Medical Affairs
Sold on a plan
1,378
$10.29
$14.18K
Richard A Graham
14 Nov 2023
SVP, Research & Development
Sold on a plan
2,482
$10.22
$25.37K
Richard A Graham
16 Oct 2023
SVP, Research & Development
Sold on a plan
2,482
$9.03
$22.41K
Richard A Graham
14 Sep 2023
SVP, Research & Development
Sold on a plan
2,482
$9.89
$24.55K
Rhonda Farnum
22 Aug 2023
SVP, Comm & Medical Affairs
Sold on a plan
1,807
$9.47
$17.11K
Richard A Graham
11 Aug 2023
SVP, Research & Development
Sold on a plan
2,322
$9.99
$23.20K
Richard A Graham
14 Jul 2023
SVP, Research & Development
Sell
2,322
$9.84
$22.85K
Richard A Graham
14 Jun 2023
SVP, Research & Development
Sell
2,322
$10.69
$24.82K
Rhonda Farnum
8 Jun 2023
SVP, Comm & Medical Affairs
Sell
1,790
$11.13
$19.92K
Richard A Graham
15 May 2023
SVP, Research & Development
Sell
2,322
$11.26
$26.15K
Richard A Graham
14 Apr 2023
SVP, Research & Development
Sell
2,323
$11.88
$27.60K
Richard A Graham
14 Mar 2023
SVP, Research & Development
Sell
2,323
$10.32
$23.97K
Rhonda Farnum
9 Mar 2023
SVP, Comm & Medical Affairs
Sell
4,000
$10.20
$40.80K
Richard A Graham
6 Mar 2023
SVP, Research & Development
Sell
2,323
$10.05
$23.35K
Rick E Winningham
14 Dec 2022
Chief Executive Officer
Sell
50,000
$11.19
$559.50K
Richard A Graham
1 Dec 2022
SVP, Research & Development
Sell
2,084
$10.73
$22.36K
Andrew A. Hindman
18 Nov 2022
SVP, Chief Financial Officer
Sell
65,000
$11.02
$716.24K
Richard A Graham
16 Aug 2022
SVP, Development
Sell
4,906
$9.71
$47.64K
Richard A Graham
9 Aug 2022
SVP, Development
Sell
15,086
$8.79
$132.61K
Rhonda Farnum
23 May 2022
SVP, Comm & Medical Affairs
Sell
1,081
$8.93
$9.65K
Rhonda Farnum
28 Feb 2022
SVP, Comm & Medical Affairs
Sell
2,356
$10.16
$23.95K
Philip D Worboys
9 Mar 2021
SVP, Research & Transl Science
Sell
8,829
$20.00
$176.58K
Richard A Graham
14 Dec 2020
SVP, Development
Sell
7,500
$19.47
$146.06K
Philip D Worboys
3 Dec 2020
SVP, Research & Transl Science
Sell
4,246
$18.00
$76.43K
Brett K Haumann
21 Aug 2020
Chief Medical Officer
Sell
25,000
$18.29
$457.24K
Philip D Worboys
20 Aug 2020
SVP, Research & Transl Science
Sell
17,103
$18.00
$307.85K
Vijay Sabesan
12 Dec 2019
SVP, Technical Operations
Sell
1,027
$21.03
$21.60K
Donal O'Connor
17 May 2019
Director
Sell
2,673
$20.19
$53.97K
Donal O'Connor
16 May 2019
Director
Sell
1,327
$21.00
$27.87K
Sharathchandra S Hegde
5 Mar 2019
SVP, Research
Sell
5,690
$24.50
$139.41K
Sharathchandra S Hegde
4 Mar 2019
SVP, Research
Sell
3,343
$25.06
$83.76K
Philip D Worboys
12 Sep 2018
SVP, Translational Science
Sell
6,393
$28.50
$182.20K
Bradford J Shafer
27 Aug 2018
EVP, Gen. Counsel, Secretary
Sell
7,119
$27.71
$197.28K
Renee D Gala
15 Aug 2018
SVP, Chief Financial Officer
Sell
1,700
$27.43
$46.62K
Renee D Gala
15 Aug 2018
SVP, Chief Financial Officer
Sell
39,839
$26.71
$1.06M
Renee D Gala
14 Aug 2018
SVP, Chief Financial Officer
Sell
2,204
$27.74
$61.14K
Bradford J Shafer
8 Aug 2018
EVP, Gen. Counsel, Secretary
Sell
25,355
$27.85
$706.18K
Bradford J Shafer
7 Aug 2018
EVP, Gen. Counsel, Secretary
Sell
4,127
$28.03
$115.69K
Bradford J Shafer
7 Aug 2018
EVP, Gen. Counsel, Secretary
Sell
1,818
$28.99
$52.71K
Bradford J Shafer
8 Jun 2018
EVP, Gen. Counsel, Secretary
Sell
3,900
$23.66
$92.26K
Bradford J Shafer
6 Jun 2018
EVP, Gen. Counsel, Secretary
Sell
10,140
$24.09
$244.27K
Burton G Malkiel
21 May 2018
Director
Buy
1,000
$22.54
$22.54K
Renee D Gala
18 May 2018
SVP, Chief Financial Officer
Sell
10,000
$24.29
$242.88K
Bradford J Shafer
6 Sep 2017
EVP, Gen. Counsel, Secretary
Sell
14,670
$30.77
$451.35K
Frank Pasqualone
21 Aug 2017
SVP, Chief Comm Ops Officer
Buy
4,000
$26.34
$105.36K
Rick E Winningham
11 Aug 2017
Chief Executive Officer
Buy
10,000
$24.50
$245.00K
Henrietta Fore
11 Aug 2017
Director
Buy
6,000
$23.99
$143.93K
Burton G Malkiel
11 Aug 2017
Director
Buy indirect
15,000
$24.59
$368.82K
Burton G Malkiel
11 Aug 2017
Director
Buy
15,000
$24.59
$368.85K
George M Whitesides
11 Aug 2017
Director
Buy indirect
4,000
$24.69
$98.76K
Brett K Haumann
7 Mar 2017
SVP Clin Dev & Chief Med Ofc
Sell
424
$30.80
$13.06K
Brett K Haumann
6 Mar 2017
SVP Clin Dev & Chief Med Ofc
Sell
13,576
$31.52
$427.92K
Bradford J Shafer
3 Mar 2017
EVP, Gen. Counsel, Secretary
Sell
26,829
$31.86
$854.77K

What was left out

Form 4 filings counted 515
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 1
Joint filings 1
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 5
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 30,222,989
Sales filed before the plan box existed 35
History held since 19 May 2014